Home/Filings/4/0001209191-22-044269
4//SEC Filing

Haley Pamela 4

Accession 0001209191-22-044269

CIK 0001469443other

Filed

Aug 2, 8:00 PM ET

Accepted

Aug 3, 5:23 PM ET

Size

5.4 KB

Accession

0001209191-22-044269

Insider Transaction Report

Form 4
Period: 2022-08-01
Haley Pamela
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2022-08-01$0.70/sh+700$4905,088 total
Footnotes (2)
  • [F1]Reflects the purchase of 700 shares of the Issuer's common stock on 8/1/22 at a per share purchase price of $0.70 pursuant to participation in the Issuer's 2015 Employee Stock Purchase Plan ("ESPP"). This transaction is exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's common stock.
  • [F2]The amount includes the 2015 Employee Stock Purchase Plan ("ESPP") purchases, for the purchase period of August 4, 2020 to August 1, 2022. These transactions were exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's Common Stock on the date of each respective purchase.

Issuer

Arcadia Biosciences, Inc.

CIK 0001469443

Entity typeother

Related Parties

1
  • filerCIK 0001787373

Filing Metadata

Form type
4
Filed
Aug 2, 8:00 PM ET
Accepted
Aug 3, 5:23 PM ET
Size
5.4 KB